SLC2A1 and neoplasm: Moreover, GLUT inhibitors, combined with other antiglycolytic agents, also result in superior inhibition of tumor cell metabolism, compared to such action of these agents when applied alone (Raez et al., 2013; Barbosa and Martel, 2020; Tilekar et al., 2020).